GLO1 and cancer: Moreover, since GLO1 enzymatic activity has earlier been described as a molecular factor determining chemoresistance of cancer cells to electrophilic chemotherapeutics, we also assessed the effects of two standard agents (cisplatin and dacarbazine) on viability of A375_GLO1_WT versus A375_GLO1_KO cells (Figure 2E) [8,24].